WeissLaw LLP Investigates Vectren Corporation Acquisition

18:48 EDT 24 Apr 2018 | BioMedReports - Blog

WeissLaw is investigating whether VVC's Board acted to maximize shareholder value prior to entering into the agreement.  Notably, at least one analyst set a target

Original Article: WeissLaw LLP Investigates Vectren Corporation Acquisition

More From BioPortfolio on "WeissLaw LLP Investigates Vectren Corporation Acquisition"